- €115.78bn
- €129.18bn
- €44.29bn
- 92
- 45
- 75
- 86
REG - BkofA Merrill Lynch - HORIZON THERAPEUTICS PLC_38.5 (b)_IE_BANA
AnnouncementREG - Goldman Sachs (EPT) - Form 38.5b - Horizon Therapeutics plc
AnnouncementREG - Capital Group Co. Sanofi SA Amgen Inc. - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Goldman Sachs (EPT) - 38.5b - Horizon Therapeutics plc
AnnouncementREG - Goldman Sachs & Co. - 38.5b - Horizon Therapeutics plc
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - Horizon Therapeutics Plc
AnnouncementREG - Capital Group Co. Amgen Inc. Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - Bank of NY Mel Corp - Form 8.3 - Horizon Therapeutics Plc
AnnouncementREG - Wellington Mngmnt Gp Sanofi SA - Form 8.3 - Sanofi
AnnouncementREG - BlackRock Group Sanofi SA - Form 8.3 - Sanofi
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - Sanofi
AnnouncementREG - T.Rowe Price Assoc - Form 8.3 - Horizon Therapeutics Plc
AnnouncementREG - Citadel Group Sanofi SA - Form 8.3 - Horizon Therapeutics PLC
AnnouncementREG - Irish Takeover Panel - Disclosure Table
AnnouncementREG - Citigroup Global Mkt Sanofi SA - Form 38.5(a) (EPTRI) -Sanofi
AnnouncementREG - Citigroup Glbl Mkt E Sanofi SA - Form 38.5 (b) (EPT/NON-RI)
AnnouncementREG - Capital Group Co. Sanofi SA - Form 8.3 - Sanofi SA
AnnouncementREG - Capital Group Co. Sanofi SA Amgen Inc. - Form 8.3 - Horizon Therapeutics Plc
Announcement